On the cardiovascular effects of GLP-1 from recent studies / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 后插1-4, 2010.
Article
in Chinese
| WPRIM
| ID: wpr-596443
ABSTRACT
Cardiovascular disease is the main cause of death in patients with type 2 diabetes. The protection of glucagon-like peptide-1 ( GLP-1 ) on endothelial function, ischemic myocardial damage, and heart failure have been reviewed. Based on the recently finished serial clinical studies, the effects that long-acting GLP-1 analogues liraglutide improved body weight, blood pressure, lipids, and other cardiovascular risk factors were discussed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS